510(k) · Cleared
ClearedPhilips BV300 Series Release 2.1
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Philips Medical Systems, Inc. · OXO Image-Intensified Fluoroscopic X-Ray System, Mobile
Cleared on Sep 2, 1998 as substantially equivalent to K953910 (Philips Medical Systems North America, Inc., 1995) after a 29-day review. Its family tree reaches back 1 generation to 1995.
- Decided
- Sep 2, 1998
- Review
- 29 days
- Class
- Class II
- Product code
- OXO
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K953910 (1995). No later device cites it as a predicate yet.
- Root · 1 generation backK953910 Philips BV 300 SeriesPhilips Medical Systems North America, Inc. · 1995 · Recalled
- This deviceK982706 Philips BV300 Series Release 2.1Philips Medical Systems, Inc. · 1998
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K953910 | Philips BV 300 Series | Philips Medical Systems North America, Inc. | 1995 | 1 |
| 0 (this device) | K982706 | Philips BV300 Series Release 2.1 | Philips Medical Systems, Inc. | 1998 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in OXO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new OXO device
- #1 K253296 Digital C-ARM with 3Dscore 15.1 · 13 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K953910 | Philips BV 300 SeriesSummary page 1…devices. Substantial equivalence Information The BV300 Series Release 2.1 is a modification of, and substantially equivalent to, the BV300 Series Release 1, 510(k) No. K953910. Safety Information The BV300 Series Release 2.1 complies with the applicable portions of 21 CFR parts 1020.30/.31/.32 and volu… | 1995 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Its one ancestor has a recall.
How does its category compare?
All OXO devicesOXO Image-Intensified Fluoroscopic X-Ray System, Mobile: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · OXO
4in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · OXO
97in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · OXO
4in 2024
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · OXO
118in 2025
MAUDE reports naming product code OXO, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 1 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 4 | 48 | 4 | 5 |
| 2013 | 2 | — | 3 | 41 |
| 2014 | 2 | — | 4 | 89 |
| 2015 | 1 | — | 0 | 97 |
| 2016 | 3 | 128 | 3 | 3,820 |
| 2017 | 4 | 57 | 4 | 1,697 |
| 2018 | 1 | — | 11 | 1,647 |
| 2019 | 3 | 213 | 0 | 1,297 |
| 2020 | 0 | — | 0 | 816 |
| 2021 | 2 | — | 0 | 554 |
| 2022 | 0 | — | 0 | 295 |
| 2023 | 0 | — | 0 | 275 |
| 2024 | 2 | — | 4 | 192 |
| 2025 | 4 | 97 | 0 | 118 |
| 2026 | 2 | — | 1 | — |
What is it indicated for?
The Philips BV 300 Series Release 2.1 systems are Mobile C-Arm X-Ray Systems offering Radiographic and Fluoroscopic techniques in a wide variety of applications. The series has been designed primarily for use in the operating theater.
The Philips BV300 Series Release 2.1 systems are intended for the same applications as the BV300 Series Release 1, i.e. surgical interventions needing X-ray imaging and/or guidance and interventions inside and outside the Operating Room.
This includes cerebral, thoracic, abdominal, peripheral, orthopedic and vascular procedures. The systems are also suited as a back-up for a fixed vascular X-ray system.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K982706 · printed Nov 6, 2026
Cite this page
510(k) Report. “K982706: Philips BV300 Series Release 2.1.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K982706
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026